Skip to content

Study · In vitro (cells) · 2021

10 results

The protective effects of S14G-humanin (HNG) against lipopolysaccharide (LPS)- induced inflammatory response in human dental pulp cells (hDPCs) mediated by the TLR4/MyD88/NF-κB pathway.

Zhang P, Cui Z, Li S

Bioengineered1 Dec 2021Cited by 16 (Europe PMC)

Summary

Pulpitis is reported in large populations of patients and significantly impacts their normal life quality. It is reported that the lipopolysaccharide (LPS) in Gram-negative bacteria induces severe inflammation in dental pulp tissues. S14G-humanin is a derivative of humanin and has been recently confirmed to possess promising anti-inflammatory properties. The current study aims to explore the possibility of treating pulpitis with S14G-humanin. LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis. We found the elevated expressions and production of interleukin- 6 (IL-6), tumor necrosis factor-α (TNF-α), macrophage chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), upregulated Pentraxin 3 (PTX3) and activated oxidative stress in LPS-treated DPCs were all reversed by treatment with 50 and 100 μM S14G-humanin. In addition, the LPS-induced elevated expression levels of toll-like receptor 4 (TLR4) and myeloid differentiation primary response 88 (Myd88), and activation of the IκBα/NF-κB signaling pathway in hDPCs were significantly repressed by treatment with S14G-humanin. Conclusively, we found that S14G-humanin protected LPS-treated hDPCs by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study10

10 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin at 50 and 100 μM reversed the elevated expression and production of IL-6.

    In plain wordsIn cells, S14G-humanin reversed the rise in IL-6 caused by LPS.

    Peptide
    Humanin
    Outcome
    DecreaseIL-6 expression and production
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    We found the elevated expressions and production of interleukin- 6 (IL-6), tumor necrosis factor-α (TNF-α), macrophage chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), upregulated Pentraxin 3 (PTX3) and activated oxidative stress in LPS-treated DPCs were all reversed by treatment with 50 and 100 μM S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.
  2. 02LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin at 50 and 100 μM reversed the elevated expression and production of TNF-α.

    In plain wordsIn cells, S14G-humanin reversed the rise in TNF-α caused by LPS.

    Peptide
    Humanin
    Outcome
    DecreaseTNF-α expression and production
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    We found the elevated expressions and production of interleukin- 6 (IL-6), tumor necrosis factor-α (TNF-α), macrophage chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), upregulated Pentraxin 3 (PTX3) and activated oxidative stress in LPS-treated DPCs were all reversed by treatment with 50 and 100 μM S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.
  3. 03LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin at 50 and 100 μM reversed the elevated expression and production of MCP-1.

    In plain wordsIn cells, S14G-humanin reversed the rise in MCP-1 caused by LPS.

    Peptide
    Humanin
    Outcome
    DecreaseMCP-1 expression and production
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    We found the elevated expressions and production of interleukin- 6 (IL-6), tumor necrosis factor-α (TNF-α), macrophage chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), upregulated Pentraxin 3 (PTX3) and activated oxidative stress in LPS-treated DPCs were all reversed by treatment with 50 and 100 μM S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.
  4. 04LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin at 50 and 100 μM reversed the elevated expression and production of MMP-2.

    In plain wordsIn cells, S14G-humanin reversed the rise in MMP-2 caused by LPS.

    Peptide
    Humanin
    Outcome
    DecreaseMMP-2 expression and production
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    We found the elevated expressions and production of interleukin- 6 (IL-6), tumor necrosis factor-α (TNF-α), macrophage chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), upregulated Pentraxin 3 (PTX3) and activated oxidative stress in LPS-treated DPCs were all reversed by treatment with 50 and 100 μM S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.
  5. 05LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin at 50 and 100 μM reversed the elevated expression and production of MMP-9.

    In plain wordsIn cells, S14G-humanin reversed the rise in MMP-9 caused by LPS.

    Peptide
    Humanin
    Outcome
    DecreaseMMP-9 expression and production
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    We found the elevated expressions and production of interleukin- 6 (IL-6), tumor necrosis factor-α (TNF-α), macrophage chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), upregulated Pentraxin 3 (PTX3) and activated oxidative stress in LPS-treated DPCs were all reversed by treatment with 50 and 100 μM S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.
  6. 06LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin at 50 and 100 μM reversed the upregulation of PTX3.

    In plain wordsIn cells, S14G-humanin reversed the rise in PTX3 caused by LPS.

    Peptide
    Humanin
    Outcome
    DecreasePentraxin 3 (PTX3) expression
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    We found the elevated expressions and production of interleukin- 6 (IL-6), tumor necrosis factor-α (TNF-α), macrophage chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), upregulated Pentraxin 3 (PTX3) and activated oxidative stress in LPS-treated DPCs were all reversed by treatment with 50 and 100 μM S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.
  7. 07LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin at 50 and 100 μM reversed the activated oxidative stress.

    In plain wordsIn cells, S14G-humanin reversed the oxidative stress caused by LPS.

    Peptide
    Humanin
    Outcome
    DecreaseOxidative stress
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    We found the elevated expressions and production of interleukin- 6 (IL-6), tumor necrosis factor-α (TNF-α), macrophage chemoattractant protein-1 (MCP-1), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9), upregulated Pentraxin 3 (PTX3) and activated oxidative stress in LPS-treated DPCs were all reversed by treatment with 50 and 100 μM S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.
  8. 08LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin significantly repressed the LPS-induced elevated expression of TLR4.

    In plain wordsIn cells, S14G-humanin lowered the LPS-driven rise of the receptor TLR4.

    Peptide
    Humanin
    Outcome
    DecreaseTLR4 expression
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    In addition, the LPS-induced elevated expression levels of toll-like receptor 4 (TLR4) and myeloid differentiation primary response 88 (Myd88), and activation of the IκBα/NF-κB signaling pathway in hDPCs were significantly repressed by treatment with S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.
  9. 09LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin significantly repressed the LPS-induced elevated expression of MyD88.

    In plain wordsIn cells, S14G-humanin lowered the LPS-driven rise of the signal protein MyD88.

    Peptide
    Humanin
    Outcome
    DecreaseMyD88 expression
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    In addition, the LPS-induced elevated expression levels of toll-like receptor 4 (TLR4) and myeloid differentiation primary response 88 (Myd88), and activation of the IκBα/NF-κB signaling pathway in hDPCs were significantly repressed by treatment with S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.
  10. 10LabIn vitro (cells)Mechanism

    In LPS-treated human dental pulp cells, S14G-humanin significantly repressed LPS-induced activation of the IκBα/NF-κB signaling pathway.

    In plain wordsIn cells, S14G-humanin reduced activation of the IκBα/NF-κB inflammation pathway caused by LPS.

    Peptide
    Humanin
    Outcome
    DecreaseIκBα/NF-κB pathway activation
    Study

    humann: not reported in source

    Human dental pulp cells (hDPCs) stimulated with LPS
    Comparator
    LPS-treated cells without S14G-humanin
    Outcome group
    Inflammation markers · Immune and inflammation
    Studied dose
    50 and 100 μMAs given in this study (human).

    Source sentences

    Summary
    In addition, the LPS-induced elevated expression levels of toll-like receptor 4 (TLR4) and myeloid differentiation primary response 88 (Myd88), and activation of the IκBα/NF-κB signaling pathway in hDPCs were significantly repressed by treatment with S14G-humanin.
    1 context sentence
    Summary · context
    LPS-stimulated dental pulp cells (DPCs) were utilized to simulate an inflammatory state in the progression of pulpitis.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.